Humana

Controversy surrounds Exondys 51 approval: What to knowNew medicine for Duchenne muscular dystrophy raises questions. Here’s whose covering it and why.
Three reasons for nonadherenceUncover the root causes of why patients become nonadherent and be better positioned to improve the lives of patients and reduce costs through improved health outcomes.
ACA exchanges: Who's in, who's out?What MCOs should know about insurers’ plans for the marketplace exchanges in 2018.
Humana shares its population health management secretsHumana’s goal is to improve the health of the communities it serves 20% by the year 2020. Find out how it is reaching this goal.
One plan’s unique approach to combat diabetes, obesityThis novel approach aims to help those already struggling with obesity and diabetes, but eventually win the fight against this epidemic.
Pharmacists Pushing for DIR Relief
Pharmacists Pushing for DIR ReliefCommunity pharmacists fight against financial pressure for their survival.
Healthcare mergers and acquisitions: What payers, providers will do in 2017Integrating businesses is complex, but experts shed light on other options including partnerships and shared services.
How payer mega-merger failures affect healthcare consolidation trendsHere’s how experts say the blocked Aetna-Humana and Anthem-Cigna mergers will affect consolidation among payers and providers.
Seven ways the blocked Aetna-Humana merger affects the industryThe proposed megamerger has been shot down. Find out what it means for healthcare execs.
Value-based care takes over J.P. Morgan Healthcare Conference 2017Is the drive to value-based care really accelerating? What can be done amidst all of the uncertainty? Expert shares insights from the J.P. Morgan 35th Annual Healthcare Conference.